GMEB1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.151430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.394000E-01
Normal-vs-Stage2
1.189800E-01
Normal-vs-Stage3
1.956640E-01
Normal-vs-Stage4
3.690400E-01
Stage1-vs-Stage2
8.202200E-01
Stage1-vs-Stage3
3.154200E-01
Stage1-vs-Stage4
2.541700E-03
Stage2-vs-Stage3
2.408600E-01
Stage2-vs-Stage4
1.844090E-04
Stage3-vs-Stage4
7.483900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.336630E-01
Normal-vs-AfricanAmerican
2.907200E-01
Normal-vs-Asian
7.689900E-02
Caucasian-vs-AfricanAmerican
9.912800E-01
Caucasian-vs-Asian
2.187200E-01
AfricanAmerican-vs-Asian
3.463400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.247020E-01
Normal-vs-Female
1.294020E-01
Male-vs-Female
7.199400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.972000E-01
Normal-vs-Age(41-60Yrs)
3.384200E-01
Normal-vs-Age(61-80Yrs)
7.774000E-02
Normal-vs-Age(81-100Yrs)
6.065600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.669400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.124600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.539600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.678700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.151900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.560000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.081830E-01
Normal-vs-Daily Drinker
3.169200E-01
Normal-vs-Weekly Drinker
3.268200E-01
Normal-vs-Occasional Drinker
2.299800E-01
Normal-vs-Social Drinker
2.101200E-01
Non Drinker-vs-Daily Drinker
4.241000E-01
Non Drinker-vs-Weekly Drinker
4.947200E-01
Non Drinker-vs-Occasional Drinker
2.776200E-01
Non Drinker-vs-Social Drinker
4.523800E-01
Daily Drinker-vs-Weekly Drinker
1.807630E-01
Daily Drinker-vs-Occasional Drinker
4.913500E-02
Daily Drinker-vs-Social Drinker
1.145020E-01
Weekly Drinker-vs-Occasional Drinker
8.430200E-01
Weekly Drinker-vs-Social Drinker
9.835600E-01
Occasional Drinker-vs-Social Drinker
7.908400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.668000E-01
Normal-vs-Grade 2
8.734600E-01
Normal-vs-Grade 3
8.805200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.061500E-03
Grade 1-vs-Grade 3
1.860240E-02
Grade 1-vs-Grade 4
9.668000E-01
Grade 2-vs-Grade 3
8.771800E-01
Grade 2-vs-Grade 4
8.734600E-01
Grade 3-vs-Grade 4
8.805200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.195970E-01
Normal-vs-NonDiabetic
7.824100E-02
Diabetic-vs-NonDiabetic
9.946000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.380000E-01
Normal-vs-NoPancreatitis
8.239900E-02
Pancreatitis-vs-NoPancreatitis
2.408200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.425370E-01
Normal-vs-N1
1.277590E-01
N0-vs-N1
7.195000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.667550E-01
Normal-vs-TP53-NonMutant
5.242100E-02
TP53-Mutant-vs-TP53-NonMutant
2.228200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
